ArticlePharmaceuticals (Basel, Switzerland)2024
Bufadienolides from Chansu Injection Synergistically Enhances the Antitumor Effect of Erlotinib by Inhibiting the KRAS Pathway in Pancreatic Cancer.
Yanli Guo, Yu Jin, Jie Gao, Ding Wang, Yanming Wang, Liya Shan, Mengyu Yang, Xinzhi Li, Ketao Ma
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Yanli GuoKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Yu JinKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Jie GaoInstitute of Physiology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China.
Ding WangKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Yanming WangKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.ORCID 0000-0002-4183-172X Liya ShanKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Mengyu YangKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Xinzhi LiKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Ketao MaKey Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi 832003, China.
Funding
Guiding Project of Xinjiang Production and Construction Corps 2022ZD042High-level project at Shihezi University RCZK2021B27 and RCZK202030National Natural Science Foundation of China No. 81860286School-level autonomous project at Shihezi University ZZZC202128Scientific and Technological Innovation Talents of the Corp 2023CB008-07Training Program of Tianshan Talents To Ketao MaYouth Innovation Talent Cultivation Program at Shihezi University CXPY202217
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bufadienolidesChansu injectionerlotinibKRASpancreatic cancerVenenum Bufonis
Identifiers
PMID39770538
PMCPMC11677899
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390